The Pfizer-Wyeth merger will mean changes for its meetings department. What they may be, however, is still up in the air.

The Pharma Forum will explore how the healthcare reform debate, the new post-AIG environment, and the evolving regulatory landscape—including the likely passage of the Sunshine Act—affect medical meeting professionals in 2010 and beyond

The emphasis on evidence-based medicine, technology, and guidelines brings much good. But we may be losing something along the way

We regret that there were misprints in the article “Redesigning the Model” (December 2009, page 22). For the full text of the corrected version, please go to meetingsnet.com, keywords “new funding proposal.” In our November 2010 Medical...

It's not meeting like it's 1999, but ADA is encouraged by its Hawai‘i convention.

Pharma meetings consultant Vicki Swift explains how sales training is changing from a one-off event to a strategic year-round campaign.

Brian Russell was more than a veteran in the CME field; he also was a friend and mentor.

The Accreditation Council for Continuing Medical Education was busy last year expanding its educational outreach. Among new offerings are town-hall-style meetings, three “Bridge to Quality” workshops, and a series of four regional forums held in...